To smell the immune system: Olfaction, autoimmunity and brain involvement

Autoimmunity Reviews

Volumn 6, Issue 1, 2006, Pages 54-60

  Strous, Rael D ^a,b   Shoenfeld, Yehuda ^b,c  

^a BEER YAAKOV MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Autoimmunity; Brain disease; Olfaction; Smell

Indexed keywords

ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BRAIN DISEASE; BRAIN FUNCTION; BRAIN REGION; CELL ACTIVITY; CENTRAL NERVOUS SYSTEM; CLINICAL OBSERVATION; DEPRESSION; DISEASE ASSOCIATION; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; INTERPERSONAL COMMUNICATION; MULTIPLE SCLEROSIS; NERVE CELL; NONHUMAN; OLFACTORY BULB; OLFACTORY DISCRIMINATION; OLFACTORY SYSTEM; OLFACTORY TRACT; PARKINSON DISEASE; PATHOPHYSIOLOGY; PREDICTOR VARIABLE; RECOGNITION; REVIEW; SCHIZOPHRENIA; SMELLING;

ALZHEIMER DISEASE; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BRAIN; HUMANS; OLFACTION DISORDERS; SMELL;

EID: 33750835607     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.07.002     Document Type: Review

References (40)

1. Savic I. Imaging of brain activation by odorants in humans. Curr Opin Neurobiol 12 (2002) 455-461
2. Rolls E.T. Taste, olfactory, and food texture processing in the brain, and the control of food intake. Physiol Behav 85 (2005) 45-56
3. Buck L., and Axel R. A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell 65 (1991) 175-183
4. Zhao H., Ivic L., Otaki J.M., Hashimoto M., Mikoshiba K., and Firestein S. Functional expression of a mammalian odorant receptor. Science 279 (1998) 237-241
5. Malnic B., Hirono J., Sato T., and Buck L. Combinatorial receptor codes for odors. Cell 96 (1999) 713-723
6. Mallon E.B., Brockmann A., and Schmid-Hempel P. Immune response inhibits associative learning in insects. Proc Biol Sci 270 (2003) 2471-2473
7. Song C., and Leonard B.E. The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29 (2005) 627-647
8. Kelly J.P., Wrynn A.S., and Leonard B.E. The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther 74 3 (1997) 299-316
9. Maes M., Bosmans E., Meltzer H.Y., Scharpe S., and Suy E. Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?. Am J Psychiatry 150 (1993) 1189-1193
10. Engblom D., Ek M., Saha S., Ericsson-Dahlstrand A., Jakobsson P.J., and Blomqvist A. Prostaglandins as inflammatory messengers across the blood-brain barrier. J Mol Med 80 (2002) 5-15
11. Hosoi J., Tanida M., and Tsuchiya T. Mitigation of stress-induced suppression of contact hypersensitivity by odorant inhalation. Br J Dermatol 145 (2001) 716-719
12. Hosoi J., Tanida M., and Tsuchiya T. Regulation of plasma substance P and skin mast cells by odorants. J Cutan Med Surg 7 (2003) 287-291
13. Shibata H., Fujiwara R., Iwamoto M., Matsuoka H., and Yokoyama M.M. Immunological and behavioral effects of fragrance in mice. Int J Neurosci 57 (1991) 151-159
14. Zalcman S., Kerr L., and Anisman H. Immunosuppression elicited by stressors and stressor-related odors. Brain Behav Immun 5 (1991) 262-273
15. Hawkes C.H., Shephard B.C., and Kobal G. Assessment of olfaction in multiple sclerosis: evidence of dysfunction by olfactory evoked response and identification tests. J Neurol Neurosurg Psychiatry 63 (1997) 145-151
16. Zivadinov R., Zorzon M., Monti Bragadin L., Pagliaro G., and Cazzato G. Olfactory loss in multiple sclerosis. J Neurol Sci 168 (1999) 127-130
17. Zorzon M., Ukmar M., Bragadin L.M., Zanier F., Antonello R.M., Cazzato G., et al. Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis: a clinical and MR study. Mult Scler 6 (2000) 386-390
18. Doty R.L., Li C., Mannon L.J., and Yousem D.M. Olfactory dysfunction in multiple sclerosis. Relation to plaque load in inferior frontal and temporal lobes. Ann NY Acad Sci 855 (1998) 781-786
19. Ward C.D., Hess W.A., and Calne D.B. Olfactory impairment in Parkinson's disease. Neurology 33 (1983) 943-946
20. Ponsen M.M., Stoffers D., Booij J., van Eck-Smit B.L., Wolters E.Ch., and Berendse H.W. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 56 (2004) 173-181
21. Gray A.J., Staples V., Murren K., Dhariwal A., and Bentham P. Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type. Int J Geriatr Psychiatry 16 (2001) 513-517
22. Peters J.M., Hummel T., Kratzsch T., Lotsch J., Skarke C., and Frolich L. Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques. Am J Psychiatry 160 (2003) 1995-2002
23. Serby M., Larson P., and Kalkstein D. The nature and course of olfactory deficits in Alzheimer's disease. Am J Psychiatry 148 (1991) 357-360
24. Wang J., Eslinger P.J., Smith M.B., and Yang Q.X. Functional magnetic resonance imaging study of human olfaction and normal aging. J Gerontol A Biol Sci Med Sci 60 (2005) 510-514
25. Fetissov S.O., Harro J., Jaanisk M., Jarv A., Podar I., Allik J., et al. Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proc Natl Acad Sci U S A 102 (2005) 14865-14870
26. Turetsky B.I., Moberg P.J., Arnold S.E., Doty R.L., and Gur R.E. Low olfactory bulb volume in first-degree relatives of patients with schizophrenia. Am J Psychiatry 160 (2003) 703-708
27. Kopala L.C., Good K.P., Morrison K., Bassett A.S., Alda M., and Honer W.G. Impaired olfactory identification in relatives of patients with familial schizophrenia. Am J Psychiatry 158 (2001) 1286-1290
28. Good K.P., Whitehorn D., Rui Q., Milliken H., and Kopala L.C. Olfactory identification deficits in first-episode psychosis may predict patients at risk for persistent negative and disorganized or cognitive symptoms. Am J Psychiatry 163 (2006) 932-933
29. Goudsmit N., Coleman E., Seckinger R.A., Wolitzky R., Stanford A.D., Corcoran C., et al. A brief smell identification test discriminates between deficit and non-deficit schizophrenia. Psychiatry Res 120 (2003) 155-164
30. Malaspina D., Coleman E., Goetz R.R., Harkavy-Friedman J., Corcoran C., Amador X., et al. Odor identification, eye tracking and deficit syndrome schizophrenia. Biol Psychiatry 51 (2002) 809-815
31. Seckinger R.A., Goudsmit N., Coleman E., Harkavy-Friedman J., Yale S., Rosenfield P.J., et al. Olfactory identification and WAIS-R performance in deficit and nondeficit schizophrenia. Schizophr Res 69 (2004) 55-65
32. Moberg P.J., Doty R.L., Turetsky B.I., Arnold S.E., Mahr R.N., Gur R.C., et al. Olfactory identification deficits in schizophrenia: correlation with duration of illness. Am J Psychiatry 154 (1997) 1016-1018
33. Kopala L., Good K., Martzke J., and Hurwitz T. Olfactory deficits in schizophrenia are not a function of task complexity. Schizophr Res 17 (1995) 195-199
34. Rochefort C., Gheusi G., Vincent J.D., and Lledo P.M. Enriched odor exposure increases the number of newborn neurons in the adult olfactory bulb and improves odor memory. J Neurosci 22 (2002) 2679-2689
35. Devanand D.P., Michaels-Marston K.S., Liu X., Pelton G.H., Padilla M., Marder K., et al. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry 157 (2000) 1399-1405
36. Berendse H.W., Booij J., Francot C.M., Bergmans P.L., Hijman R., Stoof J.C., et al. Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol 50 (2001) 34-41
37. Rovesti P., and Colombo E. Aromatherapy and aerosols. SPC (London) 46 (1973) 475-477
38. Haze S., Sakai K., and Gozu Y. Effects of fragrance inhalation on sympathetic activity in normal adults. Jpn J Pharmacol 90 (2002) 247-253
39. Masago R., Matsuda T., Kikuchi Y., Miyazaki Y., Iwanaga K., Harada H., et al. Effects of inhalation of essential oils on EEG activity and sensory evaluation. J Physiol Anthropol Appl Human Sci 19 (2000) 35-42
40. Komori T., Fujiwara R., Tanida M., Nomura J., and Yokoyama M.M. Effects of citrus fragrance on immune function and depressive states. Neuroimmunomodulation 2 (1995) 174-180